{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:43:53Z","timestamp":1791081833627,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":5818,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1538-7836.2006.02270.x","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T18:57:45Z","timestamp":1165949865000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Plasma fibrinogen \u03b3\u2032 chain content in the thrombotic microangiopathy syndrome"],"prefix":"10.1016","volume":"5","author":[{"given":"M.W.","family":"Mosesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Raife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Medved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Simpson\u2010Haidaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uitte De Willige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Bertina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0010","first-page":"663","article-title":"Subfractions of human fibrinogen: preparation and analysis","volume":"62","author":"Mosesson","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0015","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1021\/bi9606206","article-title":"Plasma factor XIII binds specifically to fibrinogen molecules containing \u03b3\u2032 chains","volume":"35","author":"Siebenlist","year":"1996","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0020","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1016\/S0021-9258(19)44960-0","article-title":"Human fibrinogen heterogeneities. III. Identification of \u03b3 chain variants","volume":"247","author":"Mosesson","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0025","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1073\/pnas.77.9.5069","article-title":"Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl\u2010terminal sequence in a normal gamma chain variant (\u03b3\u2032)","volume":"77","author":"Wolfenstein\u2010Todel","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0030","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/bi00313a033","article-title":"\u03b3 and \u03b3\u2032 chains of human fibrinogen are produced by alternative mRNA processing","volume":"23","author":"Chung","year":"1984","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0035","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi00524a036","article-title":"Carboxy\u2010terminal amino acid sequence of a human fibrinogen \u03b3 chain variant (\u03b3\u2032)","volume":"20","author":"Wolfenstein\u2010Todel","year":"1981","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0040","doi-asserted-by":"crossref","first-page":"23121","DOI":"10.1074\/jbc.271.38.23121","article-title":"Identification and characterization of the thrombin binding sites on fibrin","volume":"271","author":"Meh","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0049-3848(01)00273-0","article-title":"Fibrinogen Naples I (B\u03b2 A68T) non\u2010substrate thrombin binding capacities","volume":"103","author":"Meh","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0050","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/bi00303a028","article-title":"Platelet receptor recognition site on human fibrinogen. Synthesis and structure\u2013function relationship of peptides corresponding to the C\u2010terminal segment of the \u03b3 chain","volume":"23","author":"Kloczewiak","year":"1984","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0055","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood.V79.10.2643.bloodjournal79102643","article-title":"Characterization of the \u03b3 chain platelet binding site on fibrinogen fragment D","volume":"79","author":"Kirschbaum","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0037-1613536","article-title":"Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation","volume":"89","author":"Mosesson","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0065","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood-2005-01-0240","article-title":"Studies on the basis for the properties of fibrin produced from fibrinogen containing \u03b3\u2032 chains","volume":"106","author":"Siebenlist","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0070","doi-asserted-by":"crossref","first-page":"21584","DOI":"10.1074\/jbc.M300545200","article-title":"Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin","volume":"278","author":"Pospisil","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1538-7836.2003.00027.x","article-title":"Fibrinogen \u03b3\u2032 chain binds thrombin exosite II","volume":"1","author":"Lovely","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0037-1615607","article-title":"The amino acid sequences in fibrin responsible for high affinity thrombin binding","volume":"85","author":"Meh","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-4838(83)90085-7","article-title":"Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma\u2010chain types with distinct molecular weights","volume":"744","author":"Francis","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0304-4165(84)90253-8","article-title":"Purification of three gamma\u2010chains with different molecular weights from normal human plasma fibrinogen","volume":"797","author":"Francis","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0095","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1073\/pnas.85.10.3358","article-title":"Carboxy\u2010terminal amino acid sequences of two large variant forms of the human plasma fibrinogen \u03b3 chain","volume":"85","author":"Francis","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0100","first-page":"S35","article-title":"Plasma gamma\u2032\/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor","volume":"10","author":"Drouet","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1613148","article-title":"Association of \u03b3A\/\u03b3\u2032 fibrinogen levels and coronary artery disease","volume":"88","author":"Lovely","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0110","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen \u03b3\u2032 levels","volume":"106","author":"Uitte de Willige","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0038-1657602","article-title":"The Leiden Thrombophilia Study (LETS)","volume":"78","author":"van der Meer","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1537-2995.2004.00626.x","article-title":"Severe deficiency of VWF\u2010cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients","volume":"44","author":"Raife","year":"2004","journal-title":"Transfusion"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0130","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/j.1538-7836.2005.01350.x","article-title":"Thrombotic thrombocytopenic purpura and its diagnosis","volume":"3","author":"Veyradier","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0135","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.V74.7.2437.2437","article-title":"The C\u2010terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin","volume":"74","author":"Haidaris","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V74.2.743.743","article-title":"Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte\u2010specific expression of gamma chain\u2010variant polypeptides","volume":"74","author":"Haidaris","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/asheducation-2004.1.407","article-title":"Recent advances in thrombotic thrombocytopenic purpura","author":"Sadler","year":"2004","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0150","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS\u201013 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood.V99.2.437","article-title":"Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor\u2010cleaving protease activity","volume":"99","author":"Raife","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Rapid physiological coagulation method in determination of fibrinogen","volume":"17","author":"Clauss","year":"1957","journal-title":"Acta Haematol"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0165","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1021\/bi962795l","article-title":"Domain structure and functional activity of the recombinant human fibrinogen gamma\u2010module (gamma148\u2013411)","volume":"36","author":"Medved","year":"1997","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/bi048266w","article-title":"Interaction of fibrin(ogen) with leukocyte receptor alpha M beta 2 (Mac\u20101): further characterization and identification of a novel binding region within the central domain of the fibrinogen gamma\u2010module","volume":"44","author":"Yakovlev","year":"2005","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0175","series-title":"NHLBI Program for Genomic Applications","author":"Nickerson","year":"2003"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0180","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0185","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C\u2010reactive protein, albumin, or leukocyte count with coronary heart disease: meta\u2010analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.18.2.265","article-title":"455G\/A polymorphism of the beta\u2010fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute\u2010phase reaction pattern of fibrinogen. REGRESS group","volume":"18","author":"de Maat","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1749-6632.2001.tb03544.x","article-title":"Fibrinogen and its degradation products as thrombotic risk factors","volume":"936","author":"Lowe","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1749-6632.2001.tb03543.x","article-title":"Fibrinogen polymorphisms and atherothrombotic disease","volume":"936","author":"Green","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0205","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1182\/blood-2003-08-2886","article-title":"Cause\u2013effect relation between hyperfibrinogenemia and vascular disease","volume":"103","author":"Kerlin","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1538-7836.2006.01716.x","article-title":"Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction","volume":"4","author":"Uitte de Willige","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0215","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Willebrand factor\u2010cleaving protease in thrombotic microangiopathies: a study of 111 cases","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor\u2010cleaving protease (ADAMTS13) in patients with sepsis\u2010induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0230","first-page":"415","article-title":"Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura","volume":"108","author":"Glas\u2010Greenwalt","year":"1986","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0235","first-page":"101","article-title":"Role of fibrinolysis in thrombotic thrombocytopenic purpura","volume":"24","author":"Kwaan","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ajh.2830300104","article-title":"Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von Willebrand factor and protein S","volume":"30","author":"Takahashi","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-0038-1646451","article-title":"Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic\u2013uremic syndrome","volume":"66","author":"Monteagudo","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0250","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1160\/TH05-04-0279","article-title":"Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency","volume":"94","author":"Krieg","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02270.x_bb0255","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2004-03-1101","article-title":"Proteolytic inactivation of ADAMTS13 by thrombin and plasmin","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02270.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622079521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622079521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02270.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:40:56Z","timestamp":1761532856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622079521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1538783622079521"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02270.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma fibrinogen \u03b3\u2032 chain content in the thrombotic microangiopathy syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02270.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}